Cécile Orsini

Title: Cécile Orsini: Innovator in Gene Therapy

Introduction

Cécile Orsini is a prominent inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly through his work with adenoviruses. With a total of 5 patents, Orsini's innovations have the potential to impact medical treatments and therapeutic approaches.

Latest Patents

Among his latest patents, Cécile Orsini has developed viable contaminant particle-free adenoviruses and novel adenovirus-derived viral vectors. These patents detail the preparation and use of recombinant adenoviruses, which include an inactivated E1 region and modified genomic organization. Additionally, he has disclosed recombinant adenoviruses containing an inducible promoter that controls the expression of nucleic acid sequences coding for viral genes. These advancements are crucial for preparing adeno-associated viruses (AAVs) and developing pharmaceutical compositions that utilize these innovative adenoviruses.

Career Highlights

Cécile Orsini has worked with notable companies in the pharmaceutical industry, including Rhône-Poulenc Rorer S.A. and Aventis Pharma S.A. His experience in these organizations has allowed him to refine his expertise in the development of gene therapy solutions.

Collaborations

Throughout his career, Orsini has collaborated with esteemed colleagues such as Patrice Yeh and Michel Perricaudet. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Cécile Orsini's work in the field of gene therapy exemplifies innovation and dedication to improving medical treatments. His patents and collaborations highlight his significant contributions to the scientific community.